RECURRENT PROSTATE CANCER
Clinical trials for RECURRENT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New short radiation course aims to stop returning prostate cancer
Disease control OngoingThis trial is testing a new way to treat prostate cancer that returns after the prostate has been removed. It combines a very short course of highly targeted radiation (just 5 sessions) with 6 months of hormone therapy. The goal is to see if this approach can control the cancer w…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Triple therapy shows promise for aggressive prostate cancer
Disease control OngoingThis early-phase study tested a combination of enzalutamide (a hormone-blocking drug), radiation therapy, and standard hormone therapy in 25 men with intermediate or high-risk prostate cancer. The main goal was to check for side effects and find the best way to give the treatment…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New radiation cocktail aims to cut prostate cancer treatment time
Disease control OngoingThis phase 1 trial tests a combination of two radiation techniques for men with intermediate risk prostate cancer. First, a high dose of radiation is placed inside the prostate for 10-20 minutes (brachytherapy), followed by three weeks of highly targeted external radiation (SBRT)…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 26, 2026 16:10 UTC
-
New radioactive tracer aims to illuminate hidden prostate cancer
Diagnosis OngoingThis early-phase trial tests TRDC002, a radioactive tracer that attaches to PSMA proteins on prostate cancer cells, to improve PET/CT imaging in patients whose cancer has returned or spread. Six adults with PSMA-positive recurrent or metastatic prostate cancer will receive a sing…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: C Ray Therapeutics • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Diet before chemo may cut side effects in breast and prostate cancer
Symptom relief OngoingThis study tests whether eating a low-calorie diet before chemotherapy can reduce side effects like fatigue, nausea, and mouth sores, and also improve how well the treatment works. About 130 people with breast or prostate cancer will be randomly assigned to either follow the diet…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New radiation approach aims to safely target returning prostate cancer
Symptom relief OngoingThis early-stage study tests a high-precision radiation treatment called stereotactic body radiation therapy (SBRT) for men whose prostate cancer has returned after surgery. The main goal is to find the safest dose by monitoring side effects in 26 participants. The treatment deli…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC